Immuneering (IMRX) Assets: 2020-2024
Historic Assets for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to $68.6 million.
- Immuneering's Assets fell 39.80% to $68.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $68.6 million, marking a year-over-year decrease of 39.80%. This contributed to the annual value of $102.6 million for FY2023, which is 16.17% down from last year.
- Immuneering's Assets amounted to $68.6 million in Q3 2024, which was down 11.07% from $77.1 million recorded in Q2 2024.
- Immuneering's 5-year Assets high stood at $166.7 million for Q4 2021, and its period low was $38.4 million during Q4 2020.
- Over the past 3 years, Immuneering's median Assets value was $113.9 million (recorded in 2023), while the average stood at $112.1 million.
- As far as peak fluctuations go, Immuneering's Assets surged by 333.87% in 2021, and later plummeted by 39.80% in 2024.
- Over the past 5 years, Immuneering's Assets (Quarterly) stood at $38.4 million in 2020, then soared by 333.87% to $166.7 million in 2021, then dropped by 26.60% to $122.4 million in 2022, then declined by 16.17% to $102.6 million in 2023, then plummeted by 39.80% to $68.6 million in 2024.
- Its last three reported values are $68.6 million in Q3 2024, $77.1 million for Q2 2024, and $88.0 million during Q1 2024.